Atara Biotherapeutics, Inc. 10-Q filing
Filed 2025-11-12 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-276219
- Form type
- 10-Q
- CIK
- 0001604464
- Primary document
- https://www.sec.gov/Archives/edgar/data/1604464/000119312525276219/atra-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Atara Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $119.2M | - | - |
| Operating Income | $38.4M | - | - |
| Net Income | $36.1M | - | - |
| Eps Basic | 2.96 | - | - |
| Eps Diluted | 2.93 | - | - |
| Cash And Equivalents | $5.7M | - | - |
| Total Assets | $30.2M | - | - |
| Total Liabilities | $66.8M | - | - |
| Shareholders Equity | $-36.6M | - | - |
| Operating Cash Flow | $-45.2M | - | - |
| Capital Expenditures | $0 | - | - |